ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0058

Effect of Anti-inflammatory Drugs on Intestinal Epithelial Damage and Bacterial Translocation in the Adjuvant-induced Arthritis Model

Sophie Hecquet1, Perle Totoson2, Maude Tournier2, Clement Prati1, Daniel Wendling1, Céline Demougeot2 and Frank Verhoeven1, 1Service de rhumatologie, CHU de Besançon, Besançon, France, 2PEPITE EA4267, FHU INCREASE, Bourgogne Franche-Comté University, Besançon, France

Meeting: ACR Convergence 2021

Keywords: Animal Model, corticosteroids, gut, Nonsteroidal antiinflammatory drugs (NSAIDs), spondyloarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 6, 2021

Title: Spondyloarthritis Including PsA – Basic Science Poster (0046–0068)

Session Type: Poster Session A

Session Time: 8:30AM-10:30AM

Background/Purpose: The intestine is no longer considered as an organ targeted by spondyloarthritis (SpA) but also an actor of the disease alongside environmental and immunological phenomena. In patients with SpA, increased intestinal permeability (IP) and bacterial translocation (BT) has been described. Whereas anti-inflammatory drugs (non- steroidal anti-inflammatory drugs, NSAIDs, or glucocorticoids, GCs) are known to induce deleterious intestinal changes in the general population, their effects in case of arthritis have been poorly studied. This aim of this study was to determine the effect of NSAIDs and GC on bacterial translocation and intestinal integrity in rats with adjuvant-induced arthritis (AIA).

Methods: AIA was induced in 6-week-old male Lewis rats by injection at the base of the tail of Mycobacterium butyricum in incomplete Freund’s adjuvant. At first signs of arthritis, rats were treated daily with naproxen (10 mg/kg/day, i.p.), diclofenac (5mg/kg twice daily, i.p.), celecoxib (3 mg/kg/day, i.p.), prednisolone (10 mg/kg/day, i.p.) or vehicle (saline). After 21 days of treatment, intestinal damage was assessed by measure of plasma levels of intestinal Fatty Acid Binding Protein (iFABP, ELISA) and bacterial translocation by measure of serum levels of soluble CD14 (sCD14, ELISA). Joint damage was assessed by the determination of an arthritis score (Sa).

Results: Compared to vehicle, all treatments reduced arthritis score in AIA rats (p< 0.05). Compared to AIA-vehicle, treatment with prednisolone and naproxen significantly decreased both circulating iFABP and sCD14 levels. Celecoxib decreased sCD14 but had no effect on iFABP levels. Diclofenac changed neither sCD14 nor iFABP levels.

Conclusion: This study demonstrated that NSAIDs and GC induced changes in intestinal damage and bacterial translocation in arthritis. Contrary to what is observed in healthy population, none anti-inflammatory drug enhanced intestinal damage or bacterial translocation but on the contrary, prednisolone and naproxen decreased these two parameters. Of interest, our data showed that the effect of NSAIDs is not a class-effect but depends on the balance of cyclooxygenase 1/2 inhibition.


Disclosures: S. Hecquet, None; P. Totoson, None; M. Tournier, None; C. Prati, None; D. Wendling, None; C. Demougeot, None; F. Verhoeven, None.

To cite this abstract in AMA style:

Hecquet S, Totoson P, Tournier M, Prati C, Wendling D, Demougeot C, Verhoeven F. Effect of Anti-inflammatory Drugs on Intestinal Epithelial Damage and Bacterial Translocation in the Adjuvant-induced Arthritis Model [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/effect-of-anti-inflammatory-drugs-on-intestinal-epithelial-damage-and-bacterial-translocation-in-the-adjuvant-induced-arthritis-model/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/effect-of-anti-inflammatory-drugs-on-intestinal-epithelial-damage-and-bacterial-translocation-in-the-adjuvant-induced-arthritis-model/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology